At Camlin Fine Sciences (CFS), guided by our vision to be the globally preferred, trusted, and integrated provider of reliable and proven specialty ingredients, aroma ingredients, and performance chemicals, we view the world as our market.
For more than 30 years, we have supplied products and served customers both locally and across continents. Today, with over 1,350 customers in more than 80 countries, we have built an integrated specialty chemicals platform that combines consumer insight, manufacturing depth, application expertise, and global reach. Our business is structured across three verticals: Specialty Ingredients, Performance Chemicals, and Aroma Ingredients.
The strength of our integrated model begins at Dahej SEZ, India, our fully integrated manufacturing hub, where diphenol production anchors captive raw material supply across all business verticals. Our Specialty Ingredients business offers a leading portfolio of food-grade antioxidants and blends, including traditional antioxidants under the Xtendra® brand (TBHQ, BHA, BHT, and Ascorbyl Palmitate) and natural antioxidants under NaSure® (rosemary extract, green tea extract, tocopherols, and acerola extract). Our functional excellence solutions are marketed under the Ezential™ brand, which has recently expanded through the acquisition of Vinpai solutions to address clean-label requirements. Our strategic pivot toward customized blends continues to gain momentum, supported by geographic expansion and deeper customer penetration.
Our Animal Nutrition platform has grown significantly, delivering innovation-led offerings across poultry, livestock, aquaculture, and pet nutrition. The integration of Vitafor™, Belgium, a specialist in precision liquid drinking water supplement technologies, has strengthened our EU- compliant formulation capabilities and expanded our reach across Europe, Asia, and the Middle East, while extending our presence from feed mill to farm across the complete value chain.
Our Performance Chemicals business, comprising diphenol derivatives marketed under the Dinamic® brand, serves the petrochemicals, pharmaceuticals, agrochemicals, polymers, dyes and pigment industries worldwide.
Under the adorr® brand, we manufacture adorr® Vanillin Premium and adorr® Ethyl Vanillin Premium at our Dahej SEZ facility in India, serving the global food and beverage, flavour, and fragrance industries. The range also supports non-flavouring applications for the pharmaceutical and agrochemical industries. FY2026-27 marks a period of focused volume scale-up and market establishment for the vanillin business, positioning CFS as one of the world’s leading and fastest-growing producers of vanillin and ethyl vanillin.
At the heart of this journey is One CFS — a more collaborative, customer-centric organisation that is unifying capabilities across the Group and strengthening our ability to serve customers globally.
Tel.: +91 22 67001000 / 28324404
Email: secretarial@camlinfs.com
Camlin Fine Sciences Ltd.
2nd floor, In G.S. Point, CST Road, Kalina, Santacruz (East), Mumbai 400 098. India.
CIN: L74100MH1993PLC075361
For the purpose of determining materiality of an event/information and for the purpose of making disclosures to the Stock Exchanges from time to time.
AUDITORS
M/s Kalyaniwalla & Mistry LLP
Chartered Accountants, Mumbai
BANKS AND FINANCIAL INSTITUTIONS
State Bank Of India
Bank Of India
Vivriti Capital Limited
Punjab National Bank
International Finance Corporation (IFC)
Export-Import Bank of India
The Board has established sub-committees to focus on specific issues and make informed decisions within the authority entrusted to each Committee. Committees of the Board are guided by their charter, which defines their scope, powers, and composition. For information or approval, all Committee decisions and recommendations are presented to the Board.
| Name of the Director | Designation | Committee Position |
|---|---|---|
| Pradip Kanakia | Independent Director | Chairman |
| Abeezar Faizullabhoy | Independent Director | Member |
| Amol Shah | Independent Director | Member |
| M.G. Palekar | Independent Director | Member |
| Conrad D'souza | Independent Director | Member |
| Harsha Raghavan | Non-Executive Non- Independent Director | Member |
| Radhika Dudhat | Independent Director | Member |
| Jens Van Nieuwenborgh | Non-Executive Non-Independent Director | Member |
| Name of the Director | Designation | Committee Position |
|---|---|---|
| Conrad D'souza | Independent Director | Chairman |
| Abeezar Faizullabhoy | Independent Director | Member |
| Amol Shah | Independent Director | Member |
| M.G. Palekar | Independent Director | Member |
| Harsha Raghavan | Non-Executive Non-Independent Director | Member |
| Pradip Kanakia | Independent Director | Member |
| Radhika Dudhat | Independent Director | Member |
| Jens Van Nieuwenborgh | Non-Executive Non-Independent Director | Member |
| Name of the Director | Designation | Committee Position |
|---|---|---|
| M.G. Palekar | Independent Director | Chairman |
| Nirmal Momaya | Managing Director | Member |
| Ashish Dandekar | Managing Director | Member |
| Radhika Dudhat | Independent Director | Member |
| Name of the Director | Designation | Committee Position |
|---|---|---|
| M. G. Palekar | Independent Director | Chairman |
| Nirmal Momaya | Managing Director | Member |
| Ashish Dandekar | Managing Director | Member |
Other Documents
|
Disclosure Regulation 14 - SEBI (SBEB) Regulations 2021 as on 31.03.2026
|
|
|
Form ISR-4
|
|
|
CSR projects for the financial year 2024-25
|
|
|
Form ISR-1
|
|
|
Form ISR-2
|
|
|
Form ISR-3
|
|
|
Form SH-13
|
|
|
Form SH-14
|
|
|
Circular on Non-submission of "Choice of Nomination"
|
|
|
Circular on Online processing of investor service requests and complaints by RTAs
|
|
|
CSR projects for the financial year 2023-24
|
|
|
Circular on Extension of timelines for providing "choice of nomination"
|
|
|
Circular on Redressal of investor grievances through SCORES linking it to ODR platform
|
|
|
Circular on Amendment to Circular dated July 31, 2023 on ODR
|
|
|
SEBI Circular on Online Dispute Resolution dated July 31, 2023
|
|
|
Credit Rating - 27.09.2023
|
|
|
Credit Rating - 27.02.2019
|
|
|
Credit Rating - 26.12.2017
|
|
|
Credit Rating - 08.12.2017
|
|
|
Credit Rating - 07.09.2016
|
|
|
Credit Rating - 28.07.2015
|
|
|
Articles of Association
|
|
|
Memorandum of Association
|
Policies
|
Equal Opportunity Policy
|
|
|
CFSL Employee Stock Option Scheme 2021
|
|
|
CFSL Employee Stock Option Scheme 2020
|
|
|
CFSL Employee Stock Option Scheme 2018
|
|
|
Terms and Conditions of appointment of the Independent Directors
|
|
|
Whistle Blower Policy
|
|
|
Remuneration Policy for Directors
|
|
|
Policy for Determining Material Subsidiaries
|
|
|
CFS Europe S.p.A 2015, Practices & Procedures
|
|
|
General Condition of purchase - Ita
|
|
|
General Condition of purchase - Eng
|
|
|
Anti-Bribery & Anti-Corruption Policy
|
|
|
Dividend Distribution Policy
|
|
|
Policy for determination of legitimate purpose
|
|
|
Preservation of documents and Archival Policy
|
|
|
Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders
|
|
|
Policy on Materiality of and on Dealing with Related Party Transactions
|
|
|
CSR Policy
|
|
|
Code of Practices and Procedures for Fair Disclosure Unpublished Price Sensitive Information
|
|
|
Evaluation Criteria of Independent Directors
|
|
|
Nomination and Remuneration Policy
|
|
|
Code of Conduct
|
|
|
Policy for Determination of Materiality of Event or Information
|
Secretarial Compliance Report
|
Secretarial Compliance Report - 2025-26
|
|
|
Secretarial Compliance Report - 2024-25
|
|
|
Secretarial Compliance Report - 2023-24
|
|
|
Secretarial Compliance Report - 2022-23
|
|
|
Secretarial Compliance Report - 2021-22
|
|
|
Secretarial Compliance Report - 2020-21
|
|
|
Secretarial Compliance Report - 2019-20
|
|
|
Secretarial Compliance Report - 2018-19
|
Other Documents
|
Monitoring Agency Report as on 31.03.2026
|
|
|
Monitoring Agency Report as on 31.12.2025
|
|
|
Monitoring Agency Report as on 30.09.2025
|
|
|
Monitoring Agency Report as on 30.06.2025
|
|
|
Monitoring Agency Report as on 31.03.2025
|
|
|
Newspaper Advertisement regarding Basis of Allotment - 11.02.2025
|
|
|
Disclosure under Reg 30 LODR - Allotment of Rights Equity Shares - 31.01.2025
|
|
|
Newspaper Advertisement regarding the upcoming Rights Issue of the Company - 15.01.2025
|
|
|
Outcome of Securities Issue and Allotment Committee Meeting - 09.01.2025
|
|
|
Outcome of Securities Issue and Allotment Committee Meeting - 02.01.2025
|
|
|
Notice of Securities Issue and Allotment Committee Meeting - 02.01.2025
|
|
|
Outcome of Board Meeting - 22.11.2024
|
|
|
Notice of Board Meeting - 22.11.2024
|
|
|
Outcome of Board Meeting - 10.09.2024
|
|
|
Notice of Board Meeting - 10.09.2024
|